A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly

Summary Objective To evaluate the efficacy, safety and tolerability of octreotide LAR® (long‐acting repeatable octreotide) in the primary therapy of acromegaly. Design and patients Ninety‐eight previously untreated acromegalics were recruited into this prospective multicentre study. A total of 68...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical endocrinology (Oxford) 2007-06, Vol.66 (6), p.859-868
Hauptverfasser:	Mercado, Moises, Borges, Fatima, Bouterfa, Hakim, Chang, Tien-Chun, Chervin, Alberto, Farrall, Andrew J., Patocs, Attila, Petersenn, Stephan, Podoba, Jan, Safari, Mitra, Wardlaw, Joanna
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly - blood Acromegaly - drug therapy Acromegaly - pathology Adult Aged Aged, 80 and over Antineoplastic Agents, Hormonal - therapeutic use Biological and medical sciences Delayed-Action Preparations Drug Administration Schedule Endocrinopathies Feasibility Studies Female Fundamental and applied biological sciences. Psychology Gallbladder - diagnostic imaging Growth Hormone - blood Growth Hormone-Secreting Pituitary Adenoma - blood Growth Hormone-Secreting Pituitary Adenoma - drug therapy Growth Hormone-Secreting Pituitary Adenoma - pathology Humans Hypothalamus. Hypophysis. Epiphysis (diseases) Insulin-Like Growth Factor I - analysis Magnetic Resonance Imaging Male Medical sciences Middle Aged Non tumoral diseases. Target tissue resistance. Benign neoplasms Octreotide - therapeutic use Original Pituitary Neoplasms - blood Pituitary Neoplasms - drug therapy Pituitary Neoplasms - pathology Prospective Studies Treatment Outcome Ultrasonography Vertebrates: endocrinology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!